BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 22619128)

  • 1. Beyond cytomorphology: expanding the diagnostic potential for biliary cytology.
    Chadwick BE
    Diagn Cytopathol; 2012 Jun; 40(6):536-41. PubMed ID: 22619128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accuracy and morphologic aspects of pancreatic and biliary duct brushings.
    Layfield LJ; Wax TD; Lee JG; Cotton PB
    Acta Cytol; 1995; 39(1):11-8. PubMed ID: 7846997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluorescence in situ hybridization compared with conventional cytology for the diagnosis of malignant biliary tract strictures in Asian patients.
    Chaiteerakij R; Barr Fritcher EG; Angsuwatcharakon P; Ridtitid W; Chaithongrat S; Leerapun A; Baron TH; Kipp BR; Henry MR; Halling KC; Rerknimitr R; Roberts LR
    Gastrointest Endosc; 2016 Jun; 83(6):1228-35. PubMed ID: 26684604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. UroVysion Multi-Target Fluorescence in situ Hybridization Assay for the Detection of Malignant Bile Duct Brushing Specimens: A Comparison with Routine Cytology.
    Zhai J
    Acta Cytol; 2018; 62(4):295-301. PubMed ID: 29734171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Ancillary Techniques in Biliary Cytopathology Specimens.
    Layfield L
    Acta Cytol; 2020; 64(1-2):175-181. PubMed ID: 31121596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biliary brushing cytology.
    Selvaggi SM
    Cytopathology; 2004 Apr; 15(2):74-9. PubMed ID: 15056166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polysomy and p16 deletion by fluorescence in situ hybridization in the diagnosis of indeterminate biliary strictures.
    Gonda TA; Glick MP; Sethi A; Poneros JM; Palmas W; Iqbal S; Gonzalez S; Nandula SV; Emond JC; Brown RS; Murty VV; Stevens PD
    Gastrointest Endosc; 2012 Jan; 75(1):74-9. PubMed ID: 22100297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of routine cytology and fluorescence in situ hybridization for the detection of malignant bile duct strictures.
    Kipp BR; Stadheim LM; Halling SA; Pochron NL; Harmsen S; Nagorney DM; Sebo TJ; Therneau TM; Gores GJ; de Groen PC; Baron TH; Levy MJ; Halling KC; Roberts LR
    Am J Gastroenterol; 2004 Sep; 99(9):1675-81. PubMed ID: 15330900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Obscure bile duct stenosis: diagnostic management].
    Riemann JF; Damian U; Weickert U
    Dtsch Med Wochenschr; 2004 Sep; 129 Suppl 2():S133-4. PubMed ID: 15368193
    [No Abstract]   [Full Text] [Related]  

  • 10. Pancreatic and bile duct brushing cytology in 1000 cases: review of findings and comparison of preparation methods.
    Volmar KE; Vollmer RT; Routbort MJ; Creager AJ
    Cancer; 2006 Aug; 108(4):231-8. PubMed ID: 16541448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary sclerosing cholangitis as a cause of false positive bile duct brushing cytology: report of two cases.
    Layfield LJ; Cramer H
    Diagn Cytopathol; 2005 Feb; 32(2):119-24. PubMed ID: 15637668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Routine brush cytology and fluorescence in situ hybridization for assessment of pancreatobiliary strictures.
    Smoczynski M; Jablonska A; Matyskiel A; Lakomy J; Dubowik M; Marek I; Biernat W; Limon J
    Gastrointest Endosc; 2012 Jan; 75(1):65-73. PubMed ID: 22078103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective evaluation of brush cytology of biliary strictures during endoscopic retrograde cholangiopancreatography.
    Glasbrenner B; Ardan M; Boeck W; Preclik G; Möller P; Adler G
    Endoscopy; 1999 Nov; 31(9):712-7. PubMed ID: 10604612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraprocedural tissue diagnosis during ERCP employing a new cytology preparation of forceps biopsy (Smash protocol).
    Wright ER; Bakis G; Srinivasan R; Raju R; Vittal H; Sanders MK; Bernadino K; Stefan A; Blaszyk H; Howell DA
    Am J Gastroenterol; 2011 Feb; 106(2):294-9. PubMed ID: 21102569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ki-ras mutations in codon 12 and p53 mutations (biomarkers) and cytology in bile in patients with hepatobiliary-pancreatic carcinoma.
    Yamaguchi K; Nakano K; Nagai E; Chijiiwa K; Kinoshita M; Ohta M; Tanaka M
    Hepatogastroenterology; 2005; 52(63):713-8. PubMed ID: 15966189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How to improve the accuracy of diagnosis of malignant biliary strictures.
    Fogel EL; Sherman S
    Endoscopy; 1999 Nov; 31(9):758-60. PubMed ID: 10604622
    [No Abstract]   [Full Text] [Related]  

  • 17. Identification of malignant cytologic criteria in pancreatobiliary brushings with corresponding positive fluorescence in situ hybridization results.
    Barr Fritcher EG; Caudill JL; Blue JE; Djuric K; Feipel L; Maritim BK; Ragheb AA; Halling KC; Henry MR; Clayton AC
    Am J Clin Pathol; 2011 Sep; 136(3):442-9. PubMed ID: 21846921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of atypia in pancreatic and bile duct brushings: follow-up analysis of the categories atypical and suspicious for malignancy.
    Chadwick BE; Layfield LJ; Witt BL; Schmidt RL; Cox RN; Adler DG
    Diagn Cytopathol; 2014 Apr; 42(4):285-91. PubMed ID: 24167030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An Optimized Set of Fluorescence In Situ Hybridization Probes for Detection of Pancreatobiliary Tract Cancer in Cytology Brush Samples.
    Barr Fritcher EG; Voss JS; Brankley SM; Campion MB; Jenkins SM; Keeney ME; Henry MR; Kerr SM; Chaiteerakij R; Pestova EV; Clayton AC; Zhang J; Roberts LR; Gores GJ; Halling KC; Kipp BR
    Gastroenterology; 2015 Dec; 149(7):1813-1824.e1. PubMed ID: 26327129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluorescence in situ hybridization for the detection of malignant bile duct strictures: has FISH found a new pond?
    Wamsteker EJ; Anderson MA
    Am J Gastroenterol; 2004 Sep; 99(9):1682-3. PubMed ID: 15330901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.